ArticleCancers2022

HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR).

Chang W Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.